The latest installment in the 28 Years Later franchise, titled The Bone Temple, debuted with a disappointing $5.5 million domestic opening, much lower than anticipated given the series’ long-standing popularity. Featuring stars Ralph Fiennes and Cillian Murphy, the horror sequel has struggled to maintain strong numbers since its launch, raising immediate concerns about its commercial viability across both US and international markets.
Financial Pressure Mounts Amid High Production Costs
With production expenses reported at $63 million, The Bone Temple faces significant pressure to perform well at the box office. Current global earnings stand at $30.2 million, split between $15.7 million from domestic audiences as of January 20, 2026, and $14.5 million generated overseas. This slow revenue pace suggests the film is trailing behind its predecessor in early earnings.
Current Box Office Breakdown and Franchise Comparisons
Although The Bone Temple remains among the top three movies playing in US theaters, its performance is faltering compared to the original 28 Years Later film, which enjoyed stronger opening figures and steadier attendance in its initial weeks. The sequel is on track to surpass the domestic box office total of the Oscar-winning drama The Brutalist, directed by Brady Corbet and starring Adrien Brody, with an expected $16.2 million threshold set to be crossed imminently.
Critical Acclaim Contrasts with Poor Commercial Reception
The Bone Temple has earned widespread praise from critics, holding a striking 93% approval rating on Rotten Tomatoes, the highest in the Danny Boyle–Alex Garland horror franchise. Previous entries 28 Years Later and 28 Days Later carry slightly lower ratings of 88% and 87%, respectively. Yet, this critical success has not translated into audience turnout, fuelling industry apprehension about the film’s box office trajectory.
Break-Even Point and Future Prospects
To recoup its substantial costs, The Bone Temple needs to amass approximately $160 million globally. Achieving this figure remains uncertain as weekday ticket sales in the coming weeks will prove crucial in determining the film’s ultimate financial fate. The current sluggish trend casts doubt on whether The Bone Temple can reach the profitability levels required to justify its large budget.
Looking Ahead: Implications for the Franchise
The underperformance of Ralph Fiennes 28 Years Later sequel signals a worrying shift for the franchise, which has traditionally blended strong critical reception with solid box office gains. Industry watchers and fans alike will be observing the film’s performance closely in the coming days, as its ability to recover from this slow start may influence plans for future installments and the overall viability of the series moving forward.
“Domestic rankings still place the post-apocalyptic sequel among the top 3 performing titles in the US at the moment.” – Source Attribution
“The movie also holds the best critical rating in the Danny Boyle–Alex Garland horror movie franchise.” – Source Attribution
